OrthoPediatrics Corp, Hologic, Glaukos Corporation, Medtronic plc, Hill Rom Holdings, The Cooper Companies, Boston Scientific Corporation, and Becton Dickinson and Company" name="Description" /> OrthoPediatrics Corp, Hologic, Glaukos Corporation, Medtronic plc, Hill Rom Holdings, The Cooper Companies, Boston Scientific Corporation, and Becton Dickinson and Company" /> OrthoPediatrics Corp, Hologic, Glaukos Corporation, Medtronic plc, Hill Rom Holdings, The Cooper Companies, Boston Scientific Corporation, and Becton Dickinson and Company" />

The Top 8 Medical Equipment stocks to own in April 2019

This post breaks downs 8 Medical Equipment isntruments to have in your portfolio in April 2019. I will cover the following entities: OrthoPediatrics Corp, Hologic, Glaukos Corporation, Medtronic plc, Hill Rom Holdings, The Cooper Companies, Boston Scientific Corporation, and Becton Dickinson and Company
Published over a year ago
View all stories for Macroaxis | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Michael Smolkin

This list of potential positions covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty

Orthopediatrics Corp (KIDS)

The company has return on total asset (ROA) of (0.0372) % which means that it has lost $0.0372 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0555) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to -0.07 in 2024. Return On Assets is likely to drop to -0.05 in 2024. At this time, Orthopediatrics Corp's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 255.9 M in 2024, whereas Total Current Assets are likely to drop slightly above 122.2 M in 2024. The entity currently falls under 'Small-Cap' category with a current market capitalization of 686.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orthopediatrics Corp's market, we take the total number of its shares issued and multiply it by Orthopediatrics Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be undervalued. Orthopediatrics Corp holds a recent Real Value of $36.03 per share. The prevailing price of the company is $29.16. Our model determines the value of Orthopediatrics Corp from analyzing the company fundamentals such as Return On Equity of -0.0555, operating margin of (0.21) %, and Shares Outstanding of 23.55 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors support acquiring undervalued entities and selling overvalued entities since, at some point, asset prices and their ongoing real values will merge together.

Hologic (HOLX)

The company has return on total asset (ROA) of 0.0649 % which means that it generated a profit of $0.0649 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1057 %, meaning that it created $0.1057 on every $100 dollars invested by stockholders. Hologic's management efficiency ratios could be used to measure how well Hologic manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 0.09 in 2024, whereas Return On Capital Employed is likely to drop 0.08 in 2024. At this time, Hologic's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 5.1 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 3 B in 2024. The entity currently falls under 'Large-Cap' category with a current market capitalization of 18.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hologic's market, we take the total number of its shares issued and multiply it by Hologic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

1.82 Billion

At this time, Hologic's Short and Long Term Debt Total is fairly stable compared to the past year.

Glaukos Corp (GKOS)

The company has return on total asset (ROA) of (0.0796) % which means that it has lost $0.0796 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2716) %, meaning that it created substantial loss on money invested by shareholders. Glaukos Corp's management efficiency ratios could be used to measure how well Glaukos Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to -0.16 in 2024. Return On Assets is likely to drop to -0.15 in 2024. At this time, Glaukos Corp's Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 640 M in 2024, whereas Total Assets are likely to drop slightly above 549.7 M in 2024. The entity currently falls under 'Mid-Cap' category with a current market capitalization of 4.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Glaukos Corp's market, we take the total number of its shares issued and multiply it by Glaukos Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be overvalued. Glaukos Corp retains a regular Real Value of $87.65 per share. The prevalent price of the firm is $94.29. Our model calculates the value of Glaukos Corp from evaluating the firm fundamentals such as return on equity of -0.27, and Return On Asset of -0.0796 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage acquiring undervalued assets and selling overvalued assets since, at some point, asset prices and their ongoing real values will come together.

Medtronic PLC (MDT)

The company has Return on Asset of 0.0423 % which means that on every $100 spent on assets, it made $0.0423 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0817 %, implying that it generated $0.0817 on every 100 dollars invested. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.05 in 2024. Return On Assets is likely to drop to 0.04 in 2024. Total Current Liabilities is likely to gain to about 10.9 B in 2024. Liabilities And Stockholders Equity is likely to gain to about 109.8 B in 2024The entity currently falls under 'Mega-Cap' category with a total capitalization of 115.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medtronic PLC's market, we take the total number of its shares issued and multiply it by Medtronic PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

29.42 Billion

At this time, Medtronic PLC's Short and Long Term Debt Total is comparatively stable compared to the past year.

Hill Rom Holdings (HRC)

The entity beta is close to zero. As returns on the market increase, Hill-Rom Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding Hill-Rom Holdings is expected to be smaller as well. The beta indicator helps investors understand whether Hill-Rom Holdings moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if Hill-Rom deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns. The firm currently falls under 'Large-Cap' category with a total capitalization of 10.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hill-Rom Holdings's market, we take the total number of its shares issued and multiply it by Hill-Rom Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

The Cooper Companies (COO)

The company has Return on Asset of 0.0269 % which means that on every $100 spent on assets, it made $0.0269 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0387 %, implying that it generated $0.0387 on every 100 dollars invested. Cooper Companies' management efficiency ratios could be used to measure how well Cooper Companies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of March 2024, Return On Capital Employed is likely to grow to 0.05. Also, Return On Assets is likely to grow to 0.03. As of the 29th of March 2024, Total Assets is likely to grow to about 14.1 B. Also, Non Current Assets Total is likely to grow to about 12 BThe firm currently falls under 'Large-Cap' category with a total capitalization of 20.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cooper Companies's market, we take the total number of its shares issued and multiply it by Cooper Companies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

3.1 Billion

At this time, Cooper Companies' Short and Long Term Debt Total is very stable compared to the past year.

Boston Scientific Corp (BSX)

The company has Return on Asset of 0.0447 % which means that on every $100 spent on assets, it made $0.0447 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0858 %, implying that it generated $0.0858 on every 100 dollars invested. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Boston Scientific's Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to rise to 0.05 in 2024, whereas Return On Equity is likely to drop 0.06 in 2024. At this time, Boston Scientific's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 30.1 B in 2024, whereas Total Current Assets are likely to drop slightly above 3.3 B in 2024. The entity currently falls under 'Mega-Cap' category with a total capitalization of 100.86 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boston Scientific's market, we take the total number of its shares issued and multiply it by Boston Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be fairly valued. Boston Scientific Corp shows a prevailing Real Value of $69.4 per share. The current price of the firm is $68.49. Our model approximates the value of Boston Scientific Corp from analyzing the firm fundamentals such as Return On Equity of 0.0858, profit margin of 0.11 %, and Current Valuation of 109.49 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Becton Dickinson And (BDX)

The company has Return on Asset of 0.0312 % which means that on every $100 spent on assets, it made $0.0312 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0513 %, implying that it generated $0.0513 on every 100 dollars invested. Becton Dickinson's management efficiency ratios could be used to measure how well Becton Dickinson manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.05 in 2024. Return On Assets is likely to drop to 0.03 in 2024. At this time, Becton Dickinson's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 53.3 B in 2024, whereas Intangible Assets are likely to drop slightly above 603.1 M in 2024. The entity currently falls under 'Large-Cap' category with a total capitalization of 71.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Becton Dickinson's market, we take the total number of its shares issued and multiply it by Becton Dickinson's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

19.17 Billion

At this time, Becton Dickinson's Short and Long Term Debt Total is fairly stable compared to the past year.

Current Medical Equipment Recommendations


How important is Macroaxis's Liquidity

Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.

Macroaxis Gross Profit

Macroaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Macroaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Macroaxis Gross Profit growth over the last 10 years. Please check Macroaxis' gross profit and other fundamental indicators for more details.
Story appears to be empty

Orthopediatrics Corp (KIDS)

The company has return on total asset (ROA) of (0.0372) % which means that it has lost $0.0372 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0555) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to -0.07 in 2024. Return On Assets is likely to drop to -0.05 in 2024. At this time, Orthopediatrics Corp's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 255.9 M in 2024, whereas Total Current Assets are likely to drop slightly above 122.2 M in 2024. The entity currently falls under 'Small-Cap' category with a current market capitalization of 686.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orthopediatrics Corp's market, we take the total number of its shares issued and multiply it by Orthopediatrics Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be undervalued. Orthopediatrics Corp holds a recent Real Value of $36.03 per share. The prevailing price of the company is $29.16. Our model determines the value of Orthopediatrics Corp from analyzing the company fundamentals such as Return On Equity of -0.0555, operating margin of (0.21) %, and Shares Outstanding of 23.55 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors support acquiring undervalued entities and selling overvalued entities since, at some point, asset prices and their ongoing real values will merge together.

Hologic (HOLX)

The company has return on total asset (ROA) of 0.0649 % which means that it generated a profit of $0.0649 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1057 %, meaning that it created $0.1057 on every $100 dollars invested by stockholders. Hologic's management efficiency ratios could be used to measure how well Hologic manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 0.09 in 2024, whereas Return On Capital Employed is likely to drop 0.08 in 2024. At this time, Hologic's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 5.1 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 3 B in 2024. The entity currently falls under 'Large-Cap' category with a current market capitalization of 18.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hologic's market, we take the total number of its shares issued and multiply it by Hologic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

1.82 Billion

At this time, Hologic's Short and Long Term Debt Total is fairly stable compared to the past year.

Glaukos Corp (GKOS)

The company has return on total asset (ROA) of (0.0796) % which means that it has lost $0.0796 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2716) %, meaning that it created substantial loss on money invested by shareholders. Glaukos Corp's management efficiency ratios could be used to measure how well Glaukos Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to -0.16 in 2024. Return On Assets is likely to drop to -0.15 in 2024. At this time, Glaukos Corp's Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 640 M in 2024, whereas Total Assets are likely to drop slightly above 549.7 M in 2024. The entity currently falls under 'Mid-Cap' category with a current market capitalization of 4.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Glaukos Corp's market, we take the total number of its shares issued and multiply it by Glaukos Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be overvalued. Glaukos Corp retains a regular Real Value of $87.65 per share. The prevalent price of the firm is $94.29. Our model calculates the value of Glaukos Corp from evaluating the firm fundamentals such as return on equity of -0.27, and Return On Asset of -0.0796 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage acquiring undervalued assets and selling overvalued assets since, at some point, asset prices and their ongoing real values will come together.

Medtronic PLC (MDT)

The company has Return on Asset of 0.0423 % which means that on every $100 spent on assets, it made $0.0423 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0817 %, implying that it generated $0.0817 on every 100 dollars invested. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.05 in 2024. Return On Assets is likely to drop to 0.04 in 2024. Total Current Liabilities is likely to gain to about 10.9 B in 2024. Liabilities And Stockholders Equity is likely to gain to about 109.8 B in 2024The entity currently falls under 'Mega-Cap' category with a total capitalization of 115.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medtronic PLC's market, we take the total number of its shares issued and multiply it by Medtronic PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

29.42 Billion

At this time, Medtronic PLC's Short and Long Term Debt Total is comparatively stable compared to the past year.

Hill Rom Holdings (HRC)

The entity beta is close to zero. As returns on the market increase, Hill-Rom Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding Hill-Rom Holdings is expected to be smaller as well. The beta indicator helps investors understand whether Hill-Rom Holdings moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if Hill-Rom deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns. The firm currently falls under 'Large-Cap' category with a total capitalization of 10.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hill-Rom Holdings's market, we take the total number of its shares issued and multiply it by Hill-Rom Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

The Cooper Companies (COO)

The company has Return on Asset of 0.0269 % which means that on every $100 spent on assets, it made $0.0269 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0387 %, implying that it generated $0.0387 on every 100 dollars invested. Cooper Companies' management efficiency ratios could be used to measure how well Cooper Companies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of March 2024, Return On Capital Employed is likely to grow to 0.05. Also, Return On Assets is likely to grow to 0.03. As of the 29th of March 2024, Total Assets is likely to grow to about 14.1 B. Also, Non Current Assets Total is likely to grow to about 12 BThe firm currently falls under 'Large-Cap' category with a total capitalization of 20.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cooper Companies's market, we take the total number of its shares issued and multiply it by Cooper Companies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

3.1 Billion

At this time, Cooper Companies' Short and Long Term Debt Total is very stable compared to the past year.

Boston Scientific Corp (BSX)

The company has Return on Asset of 0.0447 % which means that on every $100 spent on assets, it made $0.0447 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0858 %, implying that it generated $0.0858 on every 100 dollars invested. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Boston Scientific's Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to rise to 0.05 in 2024, whereas Return On Equity is likely to drop 0.06 in 2024. At this time, Boston Scientific's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 30.1 B in 2024, whereas Total Current Assets are likely to drop slightly above 3.3 B in 2024. The entity currently falls under 'Mega-Cap' category with a total capitalization of 100.86 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boston Scientific's market, we take the total number of its shares issued and multiply it by Boston Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be fairly valued. Boston Scientific Corp shows a prevailing Real Value of $69.4 per share. The current price of the firm is $68.49. Our model approximates the value of Boston Scientific Corp from analyzing the firm fundamentals such as Return On Equity of 0.0858, profit margin of 0.11 %, and Current Valuation of 109.49 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Becton Dickinson And (BDX)

The company has Return on Asset of 0.0312 % which means that on every $100 spent on assets, it made $0.0312 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0513 %, implying that it generated $0.0513 on every 100 dollars invested. Becton Dickinson's management efficiency ratios could be used to measure how well Becton Dickinson manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.05 in 2024. Return On Assets is likely to drop to 0.03 in 2024. At this time, Becton Dickinson's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 53.3 B in 2024, whereas Intangible Assets are likely to drop slightly above 603.1 M in 2024. The entity currently falls under 'Large-Cap' category with a total capitalization of 71.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Becton Dickinson's market, we take the total number of its shares issued and multiply it by Becton Dickinson's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

19.17 Billion

At this time, Becton Dickinson's Short and Long Term Debt Total is fairly stable compared to the past year.

Current Medical Equipment Recommendations

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges